Noticeably, HLA-E/β2m overexpression profile by tumor cells was concordant between primary and paired metastatic tumors in the majority of cases (31/39, 79.5%) but discordant in 8 (20.5%) cases. This evidence concerns the gene HLA-E and metastatic neoplasm.